ESCMID eLibrary

Search results
Icon explanation








-
P1523
Cellular pharmacokinetics (accumulation, subcellular distribution, efflux) of the FabI inhibitor Debio 1452 in J774 macrophages
23 April 2018
Session: Exploring antibacterial activity with the help of pharmacology
-
P1140
Analysis of the changes in antibiotic use in the community in Belgium between 2004 and 2012: comparison between DDDs and prescription numbers, position of the fluoroquinolones, and impact of public campaigns
24 April 2017
Session: Outpatient antibiotic prescription measurement and surveys
-
eP440
Comparative in vitro activity of ceftazidime (CAZ) and ceftazidime-avibactam (CAZ-AVI) in a European collection of Pseudomonas aeruginosa from cystic fibrosis (CF) patients
10 May 2014
Session: New and old beta-lactamase inhibitors
-
P2210
Clinical safety of moxifloxacin: an analysis of "Valid for Safety" data from controlled phase II to phase IV studies performed between 1996 and 2010
03 April 2012
Session: Clinical experience with antibiotics
-
P1602
Pharmacodynamic analysis of the susceptibility of intracellular methicillin-susceptible, methicillin-resistant and linezolid-resistant Staphylococcus aureus to ceftaroline
01 April 2012
Session: Pharmacodynamic analyses and antibiotic combinations: S.aureus, MDR-Klebsiella and others
-
Improving usage by guidelines – the European experience
10 May 2011
Session: Bridging the gap of innovation – what we all could do
Search narrowed by
-
Topics
-
Type of material
-
Time period